申请人:Genentech, Inc.
公开号:US20200165260A1
公开(公告)日:2020-05-28
Compounds of Formula (00A) and salts thereof, wherein R
1
, R
2
R
3
, R
4
and n are defined herein, are useful as inhibitors of one or more Janus kinases. Also provided are pharmaceutical compositions that include a compound of Formula (00A) and a pharmaceutically acceptable carrier, adjuvant or vehicle, and methods of treating or lessening the severity of a disease or condition responsive to the inhibition of a Janus kinase activity in a patient.